Sugi Predict

Sugi Predict / Compounds / SCHEMBL23920816

SCHEMBL23920816

SCHEMBL23920816

CCCCCCCC(CCC)N1CCOCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 3/20 0.41
▸ KCNA5 P22460 2/20 0.41
▸ HTT P42858 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ LMNA P02545 5/20 0.33
▸ FDPS P14324 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ HTR2A P28223 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9224767 1.00 KCNH2 (0.41) KCNH2KCNA5HTTKMT2AMEN1
SCHEMBL19865652 0.96 KCNH2 (0.43) KCNH2KCNA5HTTKMT2AMEN1
SCHEMBL19505906 0.96 KCNH2 (0.43) KCNH2KCNA5HTTKMT2AMEN1
SCHEMBL18811892 0.96 KCNH2 (0.43) KCNH2KCNA5HTTKMT2AMEN1
SCHEMBL23381218 0.96 KCNH2 (0.43) KCNH2KCNA5HTTKMT2AMEN1
SCHEMBL18403079 0.96 KCNH2 (0.43) KCNH2KCNA5HTTKMT2AMEN1
SCHEMBL27272370 0.96 KCNH2 (0.43) KCNH2KCNA5HTTKMT2AMEN1
SCHEMBL24901344 0.92 KCNH2 (0.40) KCNH2KCNA5HTTKMT2AMEN1
SCHEMBL25921496 0.92 KCNH2 (0.39) KCNH2KCNA5HTTKMT2AMEN1
SCHEMBL25922262 0.92 KCNH2 (0.39) KCNH2KCNA5HTTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312498-A1 NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS UNIVERSITY OF MARYLAND, BALTIMORE 2023-10-05 — — US disclosed
US-11718595-B2 Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors UNIVERSITY OF MARYLAND, BALTIMORE (US) 2023-08-08 — — US disclosed
US-20220402869-A1 TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-12-22 — — US disclosed
US-20210317097-A1 NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS UNIVERSITY OF MARYLAND, BALTIMORE 2021-10-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317097-A1 NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS MAPK1, MAPK8, MAPK4 KCNH2 4534/4885KCNA5 4631/4885HTT 4230/4885
US-20230312498-A1 NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS MAPK1, MAPK8, MAPK4 KCNH2 4534/4885KCNA5 4631/4885HTT 4230/4885
US-20220402869-A1 TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF TEAD1, TEAD4, TEAD2 KCNH2 4710/4885KCNA5 3777/4885HTT 2563/4885
US-11718595-B2 Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors MAPK1, MAPK8, MAPK4 KCNH2 4534/4885KCNA5 4631/4885HTT 4230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.